Investor News Fresenius Medical Care AG & Co. KGaA Investor Relations Else-Kr ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: ir@fmc-ag.com North America: Te

Fresenius Medical Care Successfully Places

Senior Notes in the Amount of 250 million

Medical Care AG & Co. KGaA (the Company or Fresenius Medical Care ), the

world s largest provider of dialysis products and services, today announced the

pricing of Senior Notes due 2016 in the principal amount of 250million issued by FMC

Finance VI S.A., a wholly owned subsidiary of the Company (the Senior Notes ).

The coupon will be 5.50%. With a

price at issuance of 98.6636% the yield to maturity will be 5.75%. Proceeds

will be used to repay short-term indebtedness and for general corporate purposes.

The Senior Notes will be guaranteed on a senior basis jointly and

severally by the Company, Fresenius Medical Care Holdings, Inc. and Fresenius

Medical Care Deutschland GmbH.

Brosnan, Chief Financial Officer of the Company, commented: We are pleased to

have successfully completed a senior unsecured note offering. We believe it

demonstrates that investors clearly recognize our sustainable financial

strength and are confident in the future of Fresenius Medical Care and the

The Senior Notes were not registered under the

Securities Act of 1933, but were offered in an offshore transaction pursuant to Regulation S under the

Securities Act and to qualified institutional buyers in the United States

pursuant to the exemption of registration under Rule 144 A under the Securities

Act. The Senior Notes may not be offered or sold in the United States without

registration or an applicable exemption from the registration requirements.

This release does not constitute or form part of, and

should not be construed as, an offer or invitation to subscribe for, underwrite

or otherwise acquire, any securities of FMC Finance VI S.A. or Fresenius

Medical Care or any present or future member of its group nor should it or any

part of it form the basis of, or be relied on in connection with, any contract

to purchase or subscribe for any securities of FMC Finance VI S.A. or Fresenius

Medical Care or any member of its group. In particular, this release is not an

offer of securities in the United States of America (including its territories

and possessions), and securities of FMC Finance VI S.A. and Fresenius Medical

Care may not be offered or sold in the United States of America absent

registration under the Securities Act of 1933, as amended, (which FMC Finance

VI S.A. and Fresenius Medical Care do not intend to effect) or pursuant to an applicable

exemption from registration.

Fresenius Medical Care is the world s largest

integrated provider of products and services for individuals undergoing

dialysis because of chronic kidney failure, a condition that affects more than

1,770,000 individuals worldwide. Through its network of 2,509 dialysis clinics

in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius

Medical Care provides dialysis treatment to 192,804 patients around the globe

(as of 30. September 2009). Fresenius Medical Care is also the world s leading

provider of dialysis products such as hemodialysis machines, dialyzers and

related disposable products. Fresenius Medical Care is listed on the Frankfurt

Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P). For

more information about Fresenius Medical Care, visit the Company s website at www.fmc-ag.com.

release contains forward-looking statements that are subject to various risks

and uncertainties. Actual results could differ materially from those described

in these forward-looking statements due to certain factors, including changes

in business, economic and competitive conditions, regulatory reforms, foreign

exchange rate fluctuations, uncertainties in litigation or investigative

proceedings, and the availability of financing. These and other risks and

uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA s

reports filed with the U.S. Securities and Exchange Commission. Fresenius

Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking

statements in this release.